Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
News Topics
- (-) Advanced Reactors (1)
- (-) Artificial Intelligence (1)
- (-) Neutron Science (1)
- 3-D Printing/Advanced Manufacturing (1)
- Biology (1)
- Biomedical (2)
- Chemical Sciences (2)
- Climate Change (1)
- Computer Science (3)
- Coronavirus (4)
- Energy Storage (1)
- Environment (1)
- High-Performance Computing (1)
- Isotopes (1)
- Machine Learning (1)
- Materials (2)
- Materials Science (1)
- Molten Salt (1)
- Nanotechnology (3)
- Nuclear Energy (1)
- Physics (1)
- Summit (2)
- Sustainable Energy (1)
- Transportation (1)
Media Contacts
Six scientists at the Department of Energy’s Oak Ridge National Laboratory were named Battelle Distinguished Inventors, in recognition of obtaining 14 or more patents during their careers at the lab.
David Kropaczek, director of the Consortium for Advanced Simulation of Light Water Reactors, or CASL, at the Department of Energy’s Oak Ridge National Laboratory, has been named a fellow of the American Nuclear Society.
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.